Proteinase inhibitors
Executive Summary
FDA's Blood Products Advisory Committee will convene Nov. 4 to discuss alpha-1 proteinase inhibitor products and serious adverse events resulting from interference with measurement of blood glucose following infusion of maltose-containing intravenous immune globulin. The meeting will be held at the Holiday Inn in Gaithersburg, Md. at 8 a.m...